SBT-77-7101 shows favourable safety and early signs of efficacy in patients with refractory RA
News
Lincolnshire CDCs boost diagnostics with cutting-edge CT and ultrasound systems
Faster scans and same-day results improve patient experience across community sites
Opzelura shows strong results in phase 3b trial for moderate atopic dermatitis
New data support European filing for nonsteroidal topical treatment
Domain Therapeutics begins patient dosing in phase 1/2 trial of DT-7012
Domain Therapeutics has announced the first patients have been dosed in its phase 1/2 DOMISOL clinical trial of...
Evotec and Bristol Myers Squibb advance neuroscience partnership
$25m milestone payment supports pipeline progress in neurodegenerative disease research
AI model Vascul8 offers new hope for pulmonary vascular disease patients
Qureight’s imaging platform validated in peer-reviewed study
Medivir grants global rights to Biossil for remetinostat
Exclusive licensing deal aims to advance promising cancer therapy
Fezolinetant shows real-world promise for menopause symptoms
Preliminary phase 4 data highlights improvements in sleep, work productivity and quality of life
Study reveals survival benefit for CTCL patients treated with mogamulizumab
International registry highlights impact of POTELIGEO in rare lymphoma subtypes
ENA Respiratory secures US$22.4m to advance nasal spray therapy
Funding to support phase 2 trial of INNA-051 aimed at preventing viral respiratory infections
Nxera and Cancer Research UK share promising phase 1 cancer trial results
Early data from novel immunotherapy drug shows tumour response in resistant cancers
GSK and ViiV pledge £6 million to boost community-led health efforts
Global Fund welcomes private sector support ahead of phase 8 replenishment summit
Amivantamab shows promise in head and neck cancer
Subcutaneous therapy delivers 45 percent response rate in difficult-to-treat patients
Saphnelo self-injection recommended for EU approval
CHMP backs once-weekly subcutaneous option for systemic lupus erythematosus
AI tools to be trialled in next phase of MHRA’s Airlock programme
Seven new technologies selected to help transform NHS care and speed up diagnosis
